ZNF267 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.964800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.783600E-01
Normal-vs-Stage2
2.531200E-01
Normal-vs-Stage3
5.321600E-02
Normal-vs-Stage4
5.873200E-01
Stage1-vs-Stage2
7.394000E-01
Stage1-vs-Stage3
4.410200E-01
Stage1-vs-Stage4
5.293200E-01
Stage2-vs-Stage3
2.232000E-01
Stage2-vs-Stage4
5.704000E-01
Stage3-vs-Stage4
1.560570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.689560E-01
Normal-vs-AfricanAmerican
2.618800E-01
Normal-vs-Asian
3.876600E-01
Caucasian-vs-AfricanAmerican
9.210600E-01
Caucasian-vs-Asian
6.151400E-01
AfricanAmerican-vs-Asian
8.349000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.931000E-01
Normal-vs-Female
2.201600E-01
Male-vs-Female
6.751800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.146200E-01
Normal-vs-Age(41-60Yrs)
3.653600E-01
Normal-vs-Age(61-80Yrs)
1.734250E-01
Normal-vs-Age(81-100Yrs)
1.802250E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.160000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.430800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.096200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.642300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.161600E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.130200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.561230E-01
Normal-vs-Daily Drinker
7.021800E-02
Normal-vs-Weekly Drinker
1.628990E-01
Normal-vs-Occasional Drinker
2.360600E-01
Normal-vs-Social Drinker
1.029990E-01
Non Drinker-vs-Daily Drinker
2.659600E-01
Non Drinker-vs-Weekly Drinker
8.617000E-01
Non Drinker-vs-Occasional Drinker
8.065800E-01
Non Drinker-vs-Social Drinker
9.569600E-01
Daily Drinker-vs-Weekly Drinker
4.569800E-01
Daily Drinker-vs-Occasional Drinker
2.402400E-01
Daily Drinker-vs-Social Drinker
3.446600E-01
Weekly Drinker-vs-Occasional Drinker
7.240200E-01
Weekly Drinker-vs-Social Drinker
9.053000E-01
Occasional Drinker-vs-Social Drinker
7.862800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.817400E-01
Normal-vs-Grade 2
1.587710E-02
Normal-vs-Grade 3
4.665700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.005800E-02
Grade 1-vs-Grade 3
1.433610E-02
Grade 1-vs-Grade 4
3.817400E-01
Grade 2-vs-Grade 3
5.724800E-01
Grade 2-vs-Grade 4
1.587710E-02
Grade 3-vs-Grade 4
4.665700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.060560E-01
Normal-vs-NonDiabetic
1.594970E-01
Diabetic-vs-NonDiabetic
7.144600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.093820E-01
Normal-vs-NoPancreatitis
1.514840E-01
Pancreatitis-vs-NoPancreatitis
9.147800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.104420E-01
Normal-vs-N1
2.672400E-01
N0-vs-N1
5.561800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.683200E-01
Normal-vs-TP53-NonMutant
1.199200E-01
TP53-Mutant-vs-TP53-NonMutant
1.163850E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
